Past-year use of marijuana and hallucinogens, as well as binge drinking rates, for adults between the ages of 35 and 50 reached all-time highs in 2022, according to a report released on Thursday by the National Institute on Drug Abuse (NIDA).
Two-thirds of adults in the US say they or a family member have been addicted to alcohol or drugs,
...according to a report released on Thursday by the National Institute on Drug Abuse (NIDA).
Mental Health | Childhood attention-deficit / hyperactivity disorder (ADHD) was found to be associated with a “substantially poorer” health-related quality of life (HRQoL)...
...Findings from the systematic review and meta-analysis were published in the Journal of Attention Disorders.
Mental Health | Xylazine, a veterinary sedative that is not approved for human use, has been found to potentially worsen the life-threatening effects of opioids,...
...according to a study in rats that was released by the National Institutes of Health.
Two-thirds of adults in the US say they or a family member have been addicted to alcohol or drugs,...
...experienced homelessness due to addiction, or experienced an overdose that led to an emergency room visit, hospitalization, or death, according to research published this week by KFF. This figure includes 19% who say they personally have met the same criteria.
Mental Health | The first psilocybin service center to be licensed by the Oregon Health Authority under the regulatory framework created by the Oregon Psilocybin Services Act was announced this month.
...according to an observational study of Irish participants published in the Journal of Attention Disorders.
Mental Health | Cannabis is not a recommended treatment option for patients with attention-deficit/hyperactivity disorder (ADHD) due to a lack of evidence, according to a scoping review.
Researchers from the Federal University of Rio Grande do Sul, Porto Alegre, Brazil, and McMaster University, Ontario, Canada, published their findings in the Journal of Psychiatric Research.
Researchers pulled studies published through June 27, 2022, on the effect of cannabis on ADHD symptomatology and neuropsychiatric outcomes. Sourced from MEDLINE, EMBASE, EMCARE, PsycINFO, Web of Science, Cochrane Library, and Clinicaltrials.gov, the studies included experimental and observational data. Researchers examined the study population, methods, and key findings for each study.
A total of 39 studies were included, of which 1 had a randomized and placebo-controlled design. This study showed that cannabis had no effect on ADHD. Most other literature included cross-sectional studies that examined ADHD severity and its connection to cannabis use.